*MEDTRONIC EXPAND URO U.S. CLINICAL TRIAL MEETS SAFETY AND EFFECTIVENESS PRIMARY ENDPOINTS FOR HUGO™ ROBOTIC-ASSISTED SURGERY SYSTEM
*MEDTRONIC PLC - SUBMITS HUGO RAS SYSTEM TO U.S. FDA
*MEDTRONIC PLC - STUDY ACHIEVES 98.5% SURGICAL SUCCESS RATE
((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 26-APR-202518:20:02.627 GMT